Sage Therapeutics Inc.

In News

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics - TMX Newsfile

TMX Newsfile - Aug 05, 2026

Former Sage Therapeutics executives launch neurology biotech with $106M - The Business Journals

The Business Journals - Apr 21, 2026

Sage Therapeutics, Inc. (SAGE) Bought by Supernus to Boost Neuropsychiatric Portfolio - Yahoo Finance

Yahoo Finance - Sep 02, 2025

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor - Biogen

Biogen - Jul 24, 2024

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio - GlobeNewswire

GlobeNewswire - Jun 16, 2025

Sage, following setbacks, to sell to Supernus for $561M - BioPharma Dive

BioPharma Dive - Jun 16, 2025

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen - Business Wire

Business Wire - Jan 10, 2025

Sage lays off entire staff of 338 amid takeover by Supernus - Fierce Pharma

Fierce Pharma - Jun 30, 2025

Supernus completes acquisition of Sage Therapeutics for $8.50 per share - Investing.com

Investing.com - Jul 31, 2025

Jon F. Elevated to Associate Vice President of Business Development at Axsome Therapeutics, Inc. - hrtoday.in

hrtoday.in - Apr 13, 2026

Sage tumbles to record low on clinical depression pill setback - Reuters

Reuters - Aug 07, 2023

Biogen and Sage Therapeutics Complete Rolling Submission of New Drug Application for Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression - Biogen

Biogen - Dec 06, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment